Covaxin’s Phase 3 trial results show 81% efficacy
Seerat Sandhu March 6, 2021 On Wednesday, 3 March, Hyderabad-based vaccine manufacturer Bharat Biotech announced that the Phase 3 clinical results of their indigenously-made COVID-19 vaccine, Covaxin, showed...